Asia Pacific Dialysis Market size crossed USD 22.9 billion in 2020 and is set to observe around 6.1% growth rate between 2021 and 2027.

Get more details on this report - Request Free Sample PDF

The rising number of people suffering with diabetes in the region will propel the dialysis market progression. For instance, according to American Diabetes Association, around sixty percent of diabetic patients live in Asia, with one-half in India and China combined. Additionally, diabetes affects more than 138.2 million people in the Western Pacific, the world's most populated area, and the number may surge to around 201.8 million by 2035. However, several complications in the treatment may restrict the industry growth to a certain extent.

Asia Pacific Market, By Type

The hemodialysis segment will grow at 5.8% CAGR during the forecast timeline. Increasing demand for hemodialysis treatments at different dialysis centers and surging number of people suffering with end-stage renal disease are few aspects favouring the overall market expansion. Moreover, in hemodialysis the risk of infection is lower as it uses arteriovenous (AV) fistula, a gold standard vascular access that further favours the segment growth.

Asia Pacific Market, By Product & Services

Get more details on this report - Request Free Sample PDF

Equipment segment revenue exceeded USD 1.6 billion in 2020. Demand for dialysis machines have increased owing to large number of people suffering with kidney disorders. Additionally, the number of people suffering with CKD in India and the burden of kidney failure deaths in India is higher as compared to other low- and middle-income countries. Furthermore, dialysate is the fluid that helps eliminate the unwanted waste products from blood.

Asia Pacific Market, By End-use

In 2020, the in-center dialysis segment garnered over USD 16.4 billion revenue in the Asia Pacific dialysis market. During dialysis several health emergencies can occur such as gastrointestinal or cardiac problems requiring immediate hospitalization. Thus, to avoid these situations patient prefer expert supervision for better treatment and care.

Competitive Industry Landscape

Major market players include Asahi Kasei Corporation, Baxter International Inc., B Braun Melsungen AG, Fresenius Medical Care, and Nipro. These players have undertaken several business strategies including new product launches and mergers that aided them to gain a competitive position in the industry.

Asia Pacific Market, By Country

India dialysis market will exhibit more than 15% CAGR till 2027. According to the National Dialysis Program, each year nearly 2.2 lakh new patients of End Stage Renal Disease (ESRD) get added in India resulting in additional demand for 3.4 crore dialysis every year thus, proving beneficial for the country level growth. CKD patients in India tend to be much younger than other economies that surges the demand for dialysis products in this country. Furthermore, growing awareness regarding early disease diagnosis and favourable reimbursement policies will boost the country level progression.